These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17803196)

  • 1. PAMPA--critical factors for better predictions of absorption.
    Avdeef A; Bendels S; Di L; Faller B; Kansy M; Sugano K; Yamauchi Y
    J Pharm Sci; 2007 Nov; 96(11):2893-909. PubMed ID: 17803196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
    Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
    Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
    Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
    Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones.
    Bermejo M; Avdeef A; Ruiz A; Nalda R; Ruell JA; Tsinman O; González I; Fernández C; Sánchez G; Garrigues TM; Merino V
    Eur J Pharm Sci; 2004 Mar; 21(4):429-41. PubMed ID: 14998573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes.
    Kobayashi S; Nagai T; Konishi Y; Tanabe S; Morimoto K; Ogihara T
    J Pharm Pharmacol; 2012 Jan; 64(1):52-60. PubMed ID: 22150672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of PAMPA-models to predict BBB permeability including efflux ratio, plasma protein binding and physicochemical parameters.
    Mensch J; Jaroskova L; Sanderson W; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Int J Pharm; 2010 Aug; 395(1-2):182-97. PubMed ID: 20635475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
    Tam KY; Avdeef A; Tsinman O; Sun N
    J Med Chem; 2010 Jan; 53(1):392-401. PubMed ID: 19947605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAMPA--a drug absorption in vitro model. 5. Unstirred water layer in iso-pH mapping assays and pKa(flux)--optimized design (pOD-PAMPA).
    Ruell JA; Tsinman KL; Avdeef A
    Eur J Pharm Sci; 2003 Dec; 20(4-5):393-402. PubMed ID: 14659483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAMPA--a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates.
    Avdeef A; Nielsen PE; Tsinman O
    Eur J Pharm Sci; 2004 Aug; 22(5):365-74. PubMed ID: 15265506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rise of PAMPA.
    Avdeef A
    Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):325-42. PubMed ID: 16922646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative QSAR studies on PAMPA/modified PAMPA for high throughput profiling of drug absorption potential with respect to Caco-2 cells and human intestinal absorption.
    Verma RP; Hansch C; Selassie CD
    J Comput Aided Mol Des; 2007; 21(1-3):3-22. PubMed ID: 17253116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the absorption of new pharmaceuticals.
    Hidalgo IJ
    Curr Top Med Chem; 2001 Nov; 1(5):385-401. PubMed ID: 11899104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is PAMPA a useful tool for discovery?
    Galinis-Luciani D; Nguyen L; Yazdanian M
    J Pharm Sci; 2007 Nov; 96(11):2886-92. PubMed ID: 17694546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-permeability profiles for drug substances: Experimental detection, comparison with human intestinal absorption and modelling.
    Oja M; Maran U
    Eur J Pharm Sci; 2018 Oct; 123():429-440. PubMed ID: 30100533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR application for the prediction of compound permeability with in silico descriptors in practical use.
    Nakao K; Fujikawa M; Shimizu R; Akamatsu M
    J Comput Aided Mol Des; 2009 May; 23(5):309-19. PubMed ID: 19241121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.